Predictive in silico off-target profiling in drug discovery

Area of Science:

• Pharmacology
• Computational Biology
• Drug Discovery

Background:

• Drug action is a complex interplay between molecules and biological regulatory networks.
• Both intended therapeutic effects and unintended side effects stem from interactions with multiple protein targets.
• Polypharmacology, where drugs interact with numerous targets, is increasingly recognized, even for existing medications.

Purpose of the Study:

• To highlight the significance of in vitro and in silico profiling in drug discovery.
• To emphasize the role of these methods in identifying and mitigating off-target liabilities.
• To showcase the value of computational approaches in optimizing drug development and decision-making.

Main Methods:

• Utilizing extensive protein-ligand interaction data from in vitro profiling assays.
• Employing in silico profiling approaches that leverage large-scale biochemical data.
• Developing and applying computational models for predicting drug-target interactions.

Main Results:

• In vitro assays provide evidence of polypharmacological interactions for many drugs.
• Off-target profiling identifies potential liabilities, which can be safety-relevant.
• In silico methods complement in vitro data, aiding in the optimization of drug side effects.

Conclusions:

• In vitro and in silico profiling are essential tools in modern drug discovery.
• These methods facilitate a deeper understanding of polypharmacology.
• Computational approaches offer a promising platform for informed decision-making in pharmaceutical research.